About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Liver Disease Clinical Trials | 203 Studies Recruiting

Clinical TrialsLiver Disease

Liver Disease Clinical Trials

Browse 203 clinical trials for liver disease. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 203 trials

CompletedStudy of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)The goal of this clinical study is to understand whether the study drugs, semaglutide (SEMA) with the fixed-dose combination (FDC) of cilofexor/firsocostat (CILO/FIR), cause…NCT04971785·Birmingham, Alabama and 241 others

Related Searches

cirrhosistrials nafldtrials

Data from ClinicalTrials.govTerms

Active not recruitingSafety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH CirrhosisThis is an open-label, randomized study comparing a monitored ketogenic diet intervention using standard ketogenic diet (SKD) and standard of care (SOC) dietary recommendations…NCT04383951·Indianapolis, Indiana

UnknownUse of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)The objective of this observational study is to evaluate the clinical utility of the combined assay of 3 biomarkers: α-FP, α-FP-L3 and DCP (simultaneously measured by µTASWakoTM…NCT05781568·Castellana Grotte, Bari

CompletedA Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver CirrhosisThis is a study of experimental medication BMS-986036 given to adults with Nonalcoholic Steatohepatitis (NASH; the buildup of fat and inflammation in the liver that is not caused…NCT03486912·Madison, Alabama and 90 others

Not yet recruitingKetogenic Diet in MASLD-related cACLDThe investigators hypothesize that very low ketogenic diet could represent a new therapeutic option in the management of patients with MASLD and cACLD.NCT06537466·Palermo

Active not recruitingComparative Study Between Obeticholic Acid Versus Vitamin E in Patients with Non-alcoholic SteatohepatitisThis study aims at evaluating and comparing the protective outcomes of using Obeticholic acid versus Vitamin E in NASH patients without cirrhosis.NCT05573204·Tanta

CompletedHepatocellular Carcinoma in Patients With a Cirrhosis Due to an Alcoholic or a Non Alcoholic Fatty Liver DiseaseGlobal prevalence of Non Alcoholic Fatty Liver Diseases (NAFLD) ranges from 22% to 28%.The spectrum of these hepatic abnormalities extends from isolated steatosis to…NCT03307408·Nice

RecruitingLiver-gut Axis Study Through Identification of Liver Disease-specific MicrobiomeIn this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease…NCT06519162·Daejeon, Jung-gu

TerminatedStudy Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH CirrhosisThis seamless, adaptive, two-stage, Phase 2b/3, randomized, double-blind, multicenter, parallel-groups, placebo-controlled study will assess the efficacy, safety, and tolerability…NCT04365868·Birmingham, Alabama and 155 others

CompletedEvaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver DiseaseThe purpose of this study is to evaluate the use of phlebotomy (blood taking)as a treatment for patients with non-alcoholic fatty liver disease.NCT00641524·London, Ontario

TerminatedA Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver DiseaseThe purpose of this study is to evaluate the safety, tolerability, and drug levels of BMS-963272 compared to placebo in participants with nonalcoholic fatty liver disease (NAFLD)…NCT04766476·Cullman, Alabama and 18 others

CompletedImpact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver DiseaseThis study investigates whether a structured lifestyle program can help improve thinking skills and liver health in adults with Non-Alcoholic Fatty Liver Disease (NAFLD).NCT07294963·Peshawar, KPK and 1 other

UnknownGut Permeability and Bariatric-metabolic SurgeryIncreased intestinal permeability and dysbiosis have been causally associated with NAFLD and NASH progression.NCT05257200·Vienna

CompletedStudy of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)A multi-center evaluation of aldafermin in a randomized, double-blind, placebo-controlled study in subjects with compensated cirrhosis.NCT04210245·Glendale, Arizona and 48 others

TerminatedEffect of Probiotics in Non-alcoholic Fatty Liver Disease and SteatohepatitisThis study will evaluate the effect of probiotics, a beneficial intestinal bacteria supplement, if it will cause improvement of the non-alcoholic fatty liver disease (NAFLD) and…NCT04175392·Farmington Hills, Michigan

Not yet recruitingStudy to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)This study will test a Regeneron study drug called ALN-CIDEB to find out whether it may help treat a liver disease called MASH.NCT07631637

UnknownImpact of Time-restricted Feeding in NAFLDThis is a randomised controlled study of patients with Non-Alcoholic Fatty Liver Disease (NAFLD).NCT05220956·Mainz, Rhineland-Palatinate

Not yet recruitingNutritional Indices and Inflammatory Markers in MASLDMetabolic Dysfunction-Associated steatotic Liver Diseases MASLD affects approximately 25 percent of population. Systemic inflammation plays role in MASLD progression.NCT07834905

SuspendedA Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR)An Open-Label Part was added: This part will enroll in selected sites which are less affected by the COVID-19 pandemic.NCT04104321·Miami, Florida and 1 other

UnknownPoint-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASHThe main objective of the study is to determine the diagnostic performances of an ultraportable diagnostic ultrasound system for the assessment of liver fibrosis severity in…NCT05120557

PreviousPage 7 of 11Next